Rhythm Pharmaceuticals Inc (RYTM)

Apr 13, 2026

Assessing Rhythm Pharmaceuticals (RYTM) Valuation After A Recent Share Price Pullback - Sahm

Apr 13, 2026

Apr 12, 2026

Is Rhythm Pharmaceuticals (RYTM) Still Attractive After A 48.9% One‑Year Share Price Gain - Sahm

Apr 12, 2026

Apr 12, 2026

Avoiding Lag: Real-Time Signals in (RYTM) Movement - Stock Traders Daily

Apr 12, 2026

Apr 11, 2026

Rhythm Pharmaceuticals (RYTM) reports phase 3 EMANATE trial topline results for setmelanotide - MSN

Apr 11, 2026

Apr 10, 2026

Risk Analysis: Is Rhythm Pharmaceuticals Inc gaining market share2026 Outlook & Reliable Price Action Trade Plans - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

RYTM Technical Analysis | Trend, Signals & Chart Patterns | RHYTHM PHARMACEUTICALS INC (NASDAQ:RYTM) - ChartMill

Apr 10, 2026

Apr 09, 2026

Rhythm Pharmaceuticals to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026 - The Manila Times

Apr 09, 2026

Apr 09, 2026

Should I trade or invest in Rhythm Pharmaceuticals Inc2026 Fundamental Recap & Real-Time Buy Signal Alerts - baoquankhu1.vn

Apr 09, 2026

Apr 08, 2026

Why Rhythm Pharmaceuticals (RYTM) Is Up 12.6% After EU IMCIVREE Expansion Boost and Board Refresh – And What's Next - Sahm

Apr 08, 2026

Apr 07, 2026

Dip Buying: Is Rhythm Pharmaceuticals Inc currently under institutional pressureGap Down & Weekly Breakout Stock Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Momentum Shift: What are Rhythm Pharmaceuticals Incs growth leversWeekly Trade Analysis & Weekly Setup with High ROI Potential - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

RBC Capital Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Raises Target Price to $136 - Moomoo

Apr 07, 2026

Apr 05, 2026

Rhythm Pharmaceuticals, Inc. (RYTM) stock price, news, quote and history - Yahoo Finance UK

Apr 05, 2026

Apr 05, 2026

A Look At Rhythm Pharmaceuticals (RYTM) Valuation After IMCIVREE Approval Expands Obesity Treatment Reach - Sahm

Apr 05, 2026

Apr 05, 2026

Rhythm Pharma down after late-stage trial setback for lead asset in rare obesity disorders - MSN

Apr 05, 2026

Apr 04, 2026

How The Rhythm Pharmaceuticals (RYTM) Story Is Evolving After EMANATE And Imcivree Developments - Yahoo Finance

Apr 04, 2026

Apr 04, 2026

Rhythm Pharmaceuticals Setmelanotide FDA Approval, Company Details, and XBRL Filing Information - Minichart

Apr 04, 2026

Apr 04, 2026

Rhythm Pharmaceuticals Announces Changes to Board of Directors - Sahm

Apr 04, 2026

Apr 03, 2026

Rhythm Pharmaceuticals adds Kim Popovits to board of directors By Investing.com - Investing.com Australia

Apr 03, 2026

Apr 03, 2026

Rhythm Pharmaceuticals (RYTM) EVP converts RSUs, now holding 66,030 shares - Stock Titan

Apr 03, 2026

Apr 03, 2026

RHYTHM (RYTM) director receives 6,808 RSUs and 10,257 stock options - Stock Titan

Apr 03, 2026

Apr 03, 2026

Rhythm Pharmaceuticals (RYTM) director Kimberly Popovits files initial Form 3 - Stock Titan

Apr 03, 2026

Apr 03, 2026

Kim Popovits joins Rhythm (NASDAQ: RYTM) board as Ed Mathers exits - Stock Titan

Apr 03, 2026

Apr 03, 2026

Rhythm Pharmaceuticals, Inc. Announces Changes in Board of Directors - MarketScreener

Apr 03, 2026

Apr 03, 2026

Rhythm Pharmaceuticals adds Kim Popovits to board of directors - Investing.com

Apr 03, 2026

Apr 03, 2026

Rhythm Pharmaceuticals Appoints Kim Popovits to Board - citybiz

Apr 03, 2026

Apr 03, 2026

Rhythm Pharmaceuticals Announces Appointment of Kim Popovits as Director and Departure of Ed Mathers - Quiver Quantitative

Apr 03, 2026

Apr 03, 2026

Hennion & Walsh Asset Management Inc. Trims Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM - MarketBeat

Apr 03, 2026

Apr 02, 2026

Strength seen in Rhythm Pharmaceuticals (RYTM): Can its 12.6% jump turn into more strength? - MSN

Apr 02, 2026

Apr 02, 2026

Rhythm posts first FDA approval for acquired hypothalamic obesity - Longevity.Technology

Apr 02, 2026

Apr 01, 2026

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength? - qz.com

Apr 01, 2026

Apr 01, 2026

Rhythm Pharma higher after FDA label expansion for lead drug - MSN

Apr 01, 2026

Apr 01, 2026

Rhythm Pharmaceuticals: Imcivree FDA Approval & Market Growth in 2025News and Statistics - IndexBox

Apr 01, 2026

Apr 01, 2026

Rhythm Pharma wins EU backing to expand Imcivree label - MSN

Apr 01, 2026

Apr 01, 2026

Discipline and Rules-Based Execution in RYTM Response - Stock Traders Daily

Apr 01, 2026

Mar 31, 2026

Rhythm Pharmaceuticals Surges After FDA Approval for Obesity Treatment - StocksToTrade

Mar 31, 2026

Mar 31, 2026

RYTM PE Ratio & Valuation, Is RYTM Overvalued - Intellectia AI

Mar 31, 2026

Mar 31, 2026

Rhythm Pharmaceuticals’ Stock Jumps After New Drug Approval - timothysykes.com

Mar 31, 2026

Mar 31, 2026

FDA’s Approval Sparks Optimism for Rhythm Pharmaceuticals - stockstotrade.com

Mar 31, 2026

Mar 31, 2026

Rhythm Pharmaceuticals (NASDAQ:RYTM) Trading 10.9% HigherShould You Buy? - MarketBeat

Mar 31, 2026

Mar 31, 2026

Jefferies Maintains Rhythm Pharmaceuticals(RYTM.US) With Buy Rating, Maintains Target Price $125 - Moomoo

Mar 31, 2026